Ratings changes for CoreWeave, Cisco Systems, Micron Technology, Lipocine, Oruka Therapeutics, Firefly Aerospace, Digi International and more...Upgrade to MarketBeat All Access to get our best stock ideas, proprietary research, portfolio monitoring tools, and more. Start Your Free Trial.

November 13th, 2025

Forget AI, This Will Be the Next Big Tech Breakthrough (ad)

After picking Nvidia in 2016, before it jumped 27,000%...

Jeff Brown is back with what he believes will be the biggest paradigm shift ever.

Yes, even bigger than AI. And he found one Seattle company that's at the center of this new $100 trillion revolution.

Click here to get the name of this company, completely free of charge...

Click here for the details.

Today's Top Stories

Oklo’s Meltdown Is Over: A Robust Rebound Lies Ahead

By Thomas Hughes | November 13, 2025 08:22 AM

$4,200 gold is nice ... but here’s what most gold bugs are missing (Ad)

By Weiss Ratings

As Warren Buffett Nears His Exit, Berkshire's Amassed Record Cash

By Jordan Chussler | November 13, 2025 06:08 AM

Cyberattack on car manufacturer hits UK growth in Q3 ahead of crucial budget

By The Associated Press | November 13, 2025 03:49 AM

Wall Street Missed the Reddit Boom - Don't Miss the Next AI Software Play. (Ad)

By RAD Intel

Zanzibar’s ‘solar mamas’ are trained as technicians to help light up communities

By The Associated Press | November 13, 2025 12:21 AM

The US stock market falls as Nvidia and AI stars keep weakening

By The Associated Press | November 12, 2025 10:33 PM

Quick Links

Analyst Ratings My MarketBeat Account Settings MarketBeat All Access Stock Lists Stock Screener Calculators Premium Reports Best Stocks to Buy in November

Refund From 1933: Trump’s Reset May Create Instant Wealth (ad)

Trump's Reset Can Give Birth To America's Greatest Era Yet

A 90-Year cycle may end soon, creating real wealth for early adopters

In 1933, Executive Order 6102 forced everyday Americans to hand over their gold at a fixed rate.

Everyday citizens lost a sizable amount of their hard earned wealth at the stroke of FDR's pen.

Claim Your FREE Guide Now and discover how to position yourself for this golden opportunity.

Analysts' Upgrades

ATI (NYSE:ATI) was upgraded by analysts at KeyCorp from a "sector weight" rating to an "overweight" rating. They now have a $120.00 price target on the stock. This represents a 19.8% upside from the current price of $100.16.

AutoZone (NYSE:AZO) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $4,262.00 price target on the stock, up previously from $4,090.00. This represents a 11.0% upside from the current price of $3,839.31.

Booking (NASDAQ:BKNG) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating. They now have a $6,000.00 price target on the stock. This represents a 15.3% upside from the current price of $5,202.75.

Circle Internet Group (NYSE:CRCL) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to an "overweight" rating. They now have a $100.00 price target on the stock, up previously from $94.00. This represents a 15.3% upside from the current price of $86.77.

Carpenter Technology (NYSE:CRS) was upgraded by analysts at KeyCorp from a "sector weight" rating to an "overweight" rating. They now have a $380.00 price target on the stock. This represents a 12.4% upside from the current price of $338.14.

DoorDash (NASDAQ:DASH) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating. They now have a $260.00 price target on the stock, up previously from $160.00. This represents a 29.7% upside from the current price of $200.54.

Digi International (NASDAQ:DGII) was upgraded by analysts at Craig Hallum from a "hold" rating to a "buy" rating. They now have a $45.00 price target on the stock, up previously from $30.00. This represents a 13.0% upside from the current price of $39.83.

Diversified Healthcare Trust (NASDAQ:DHC) was upgraded by analysts at Royal Bank Of Canada from an "underperform" rating to a "sector perform" rating. They now have a $5.00 price target on the stock. This represents a 5.8% upside from the current price of $4.73.

Evolent Health (NYSE:EVH) was upgraded by analysts at Stephens from an "equal weight" rating to an "overweight" rating. They now have a $7.00 price target on the stock. This represents a 59.0% upside from the current price of $4.40.

Fastenal (NASDAQ:FAST) was upgraded by analysts at Wolfe Research from an "underperform" rating to a "peer perform" rating. They now have a $43.00 price target on the stock. This represents a 5.2% upside from the current price of $40.89.

Firefly Aerospace (NASDAQ:FLY) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating. They now have a $30.00 price target on the stock, down previously from $40.00. This represents a 37.4% upside from the current price of $21.83.

Floor & Decor (NYSE:FND) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "sell" rating to a "neutral" rating. They now have a $71.00 price target on the stock, down previously from $80.00. This represents a 13.2% upside from the current price of $62.73.

Genuine Parts (NYSE:GPC) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "sell" rating to a "neutral" rating. They now have a $142.00 price target on the stock, up previously from $130.00. This represents a 9.6% upside from the current price of $129.59.

Intellicheck (NYSE:IDN) was upgraded by analysts at Northland Securities from a "market perform" rating to an "outperform" rating. They now have a $7.00 price target on the stock. This represents a 6.1% upside from the current price of $6.60.

Kimberly-Clark (NASDAQ:KMB) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating. They now have a $120.00 price target on the stock. This represents a 14.7% upside from the current price of $104.59.

Lennox International (NYSE:LII) was upgraded by analysts at Wolfe Research from an "underperform" rating to a "peer perform" rating.The current price is $485.29.

NIKE (NYSE:NKE) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $75.00 price target on the stock, up previously from $60.00. This represents a 15.2% upside from the current price of $65.09.

Trane Technologies (NYSE:TT) was upgraded by analysts at Bank of America Corporation from a "neutral" rating to a "buy" rating. They now have a $550.00 price target on the stock, up previously from $490.00. This represents a 29.3% upside from the current price of $425.31.

Tetra Tech (NASDAQ:TTEK) was upgraded by analysts at Northcoast Research from a "neutral" rating to a "buy" rating. They now have a $38.00 price target on the stock. This represents a 4.9% upside from the current price of $36.23.

View More Upgrades

$4,200 gold is nice ... but here’s what most gold bugs are missing (ad)

Gold just surged past $4,200, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold stocks — in past bull markets, these plays delivered gains as high as 5,000% to 9,800%, and Sean has now identified five companies he believes could see explosive moves in the early stages of what may be the biggest gold rally yet.

Click here to see Sean’s five top gold picks

Analysts' Downgrades

Alexandria Real Estate Equities (NYSE:ARE) was downgraded by analysts at Citizens Jmp from an "outperform" rating to a "market perform" rating.The current price is $52.87.

HCI Group (NYSE:HCI) was downgraded by analysts at Oppenheimer Holdings, Inc. from an "outperform" rating to a "market perform" rating.The current price is $184.76.

Korro Bio (NASDAQ:KRRO) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating. They now have a $11.00 price target on the stock. This represents a 73.5% upside from the current price of $6.34.

Korro Bio (NASDAQ:KRRO) was downgraded by analysts at William Blair from an "outperform" rating to a "market perform" rating.The current price is $6.34.

Korro Bio (NASDAQ:KRRO) was downgraded by analysts at Raymond James Financial, Inc. from a "strong-buy" rating to a "market perform" rating.The current price is $6.34.

Korro Bio (NASDAQ:KRRO) was downgraded by analysts at Cantor Fitzgerald from an "overweight" rating to a "neutral" rating.The current price is $6.34.

Korro Bio (NASDAQ:KRRO) was downgraded by analysts at Royal Bank Of Canada from an "outperform" rating to a "sector perform" rating.The current price is $6.34.

SoundThinking (NASDAQ:SSTI) was downgraded by analysts at Craig Hallum from a "buy" rating to a "hold" rating. They now have a $10.00 price target on the stock. This represents a 47.5% upside from the current price of $6.78.

Select Water Solutions (NYSE:WTTR) was downgraded by analysts at Northland Securities from an "outperform" rating to a "market perform" rating. They now have a $12.00 price target on the stock. This represents a 12.6% upside from the current price of $10.65.

View More Downgrades

This gold stock is STILL undervalued by 80%... (ad)

“Like buying gold for $1,000/oz”

If you could go back in time to 10+ years ago and buy gold for $1,000 an ounce, it would be one of the biggest no-brainer decisions and an easy 4X gain. But you can’t go back…

Gold analyst Garrett Goggin believes there’s a similar opportunity right now in his #1 favorite gold stock.

Own Garrett’s #1 Gold Stock Now: Click here to see the details

Analysts' New Coverage

AbbVie (NYSE:ABBV) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $280.00 price target on the stock. This represents a 17.8% upside from the current price of $237.66.

Addus HomeCare (NASDAQ:ADUS) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $120.00 price target on the stock. This represents a 7.6% upside from the current price of $111.53.

ALX Oncology (NASDAQ:ALXO) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $4.00 price target on the stock. This represents a 220.0% upside from the current price of $1.25.

Amgen (NASDAQ:AMGN) is now covered by analysts at Scotiabank. They set an "outperform" rating and a $385.00 price target on the stock. This represents a 12.4% upside from the current price of $342.43.

Aveanna Healthcare (NASDAQ:AVAH) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $11.00 price target on the stock. This represents a 23.4% upside from the current price of $8.92.

Bristol Myers Squibb (NYSE:BMY) is now covered by analysts at Scotiabank. They set a "sector perform" rating and a $45.00 price target on the stock. This represents a 9.4% downside from the current price of $49.65.

BrightSpring Health Services (NASDAQ:BTSG) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $40.00 price target on the stock. This represents a 20.9% upside from the current price of $33.08.

Certara (NASDAQ:CERT) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $9.00 price target on the stock. This represents a 6.6% upside from the current price of $8.44.

CoreWeave (NASDAQ:CRWV) is now covered by analysts at Compass Point. They set a "buy" rating and a $150.00 price target on the stock. This represents a 84.3% upside from the current price of $81.41.

Contineum Therapeutics (NASDAQ:CTNM) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $22.00 price target on the stock. This represents a 89.6% upside from the current price of $11.61.

Doximity (NASDAQ:DOCS) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $55.00 price target on the stock. This represents a 7.8% upside from the current price of $51.04.

Evolent Health (NYSE:EVH) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $7.00 price target on the stock. This represents a 59.0% upside from the current price of $4.40.

Gilead Sciences (NASDAQ:GILD) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $140.00 price target on the stock. This represents a 10.7% upside from the current price of $126.50.

Healthcare Services Group (NASDAQ:HCSG) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $20.00 price target on the stock. This represents a 14.8% upside from the current price of $17.42.

HealthEquity (NASDAQ:HQY) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $100.00 price target on the stock. This represents a 0.6% downside from the current price of $100.62.

Icon (NASDAQ:ICLR) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $175.00 price target on the stock. This represents a 5.9% upside from the current price of $165.29.

IQVIA (NYSE:IQV) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $260.00 price target on the stock. This represents a 14.3% upside from the current price of $227.57.

Johnson & Johnson (NYSE:JNJ) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $230.00 price target on the stock. This represents a 17.7% upside from the current price of $195.34.

LifeStance Health Group (NASDAQ:LFST) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $8.00 price target on the stock. This represents a 22.2% upside from the current price of $6.55.

Eli Lilly and Company (NYSE:LLY) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $1,165.00 price target on the stock. This represents a 13.2% upside from the current price of $1,029.35.

Lifeway Foods (NASDAQ:LWAY) is now covered by analysts at Benchmark Co.. They set a "buy" rating and a $35.00 price target on the stock. This represents a 56.1% upside from the current price of $22.42.

Medpace (NASDAQ:MEDP) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $600.00 price target on the stock. This represents a 0.3% downside from the current price of $601.85.

MannKind (NASDAQ:MNKD) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $7.00 price target on the stock. This represents a 35.0% upside from the current price of $5.19.

Merck & Co., Inc. (NYSE:MRK) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $105.00 price target on the stock. This represents a 12.3% upside from the current price of $93.50.

Omada Health (NASDAQ:OMDA) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $27.00 price target on the stock. This represents a 26.1% upside from the current price of $21.41.

Oruka Therapeutics (NASDAQ:ORKA) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $45.00 price target on the stock. This represents a 59.7% upside from the current price of $28.17.

Pfizer (NYSE:PFE) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $30.00 price target on the stock. This represents a 14.8% upside from the current price of $26.14.

Phreesia (NYSE:PHR) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $32.00 price target on the stock. This represents a 39.6% upside from the current price of $22.92.

Privia Health Group (NASDAQ:PRVA) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $30.00 price target on the stock. This represents a 23.4% upside from the current price of $24.31.

Regeneron Pharmaceuticals (NASDAQ:REGN) is now covered by analysts at Scotiabank. They set a "sector perform" rating and a $650.00 price target on the stock. This represents a 7.4% downside from the current price of $702.00.

Rocket Companies (NYSE:RKT) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $25.00 price target on the stock. This represents a 41.0% upside from the current price of $17.73.

Sotera Health (NASDAQ:SHC) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $19.00 price target on the stock. This represents a 16.5% upside from the current price of $16.31.

TruBridge (NASDAQ:TBRG) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $19.50 price target on the stock. This represents a 3.3% downside from the current price of $20.17.

Teladoc Health (NYSE:TDOC) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $8.00 price target on the stock. This represents a 9.8% upside from the current price of $7.29.

Trevi Therapeutics (NASDAQ:TRVI) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $13.00 price target on the stock. This represents a 9.3% upside from the current price of $11.89.

Veeva Systems (NYSE:VEEV) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $300.00 price target on the stock. This represents a 1.7% upside from the current price of $295.00.

Vital Farms (NASDAQ:VITL) is now covered by analysts at Benchmark Co.. They set a "buy" rating and a $60.00 price target on the stock. This represents a 80.5% upside from the current price of $33.24.

Vertex Pharmaceuticals (NASDAQ:VRTX) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $495.00 price target on the stock. This represents a 12.6% upside from the current price of $439.46.

Waystar (NASDAQ:WAY) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $47.00 price target on the stock. This represents a 28.2% upside from the current price of $36.67.

View More New Coverage

Calendars from MarketBeat

Dividend Declarations

Earnings Announcements

Earnings Conference Calls

FDA Calendar

Gap Up/Down Stocks

Insider Trades

Initial Public Offerings (IPOs)

Most Active Stocks

Percentage Gainers/Decliners

Sector Performance

Short Interest

Stock Splits

Unusual Options Volume

Unusual Trading Volume

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial